Predict your next investment

BUSINESS PRODUCTS & SERVICES | Education & Training (business)
fasthealthcare.com

See what CB Insights has to offer

Stage

Angel | Alive

Total Raised

$1.06M

Last Raised

$1.06M | 15 yrs ago

About FAST Healthcare

Provider of interactive e-learning courses for health, community, and social care professionals and support staff. The company offers a range of e-learning courses and tutorials ranging from clinical and non-clinical, to care of the elderly and safeguarding children. Measuring performance system is also developed to conduct course-tracking, user reports and training audits.

FAST Healthcare Headquarter Location

Suite C, The Chamber

Petersfield, GU32 3HJ,

United Kingdom

44 173 023 0555

Latest FAST Healthcare News

Fast Healthcare Interoperability Resources (FHIR)–Based Quality Information Exchange for Clinical Next-Generation Sequencing Genomic Testing: Implementation Study

Apr 28, 2021

Fast Healthcare Interoperability Resources (FHIR)–Based Quality Information Exchange for Clinical Next-Generation Sequencing Genomic Testing: Implementation Study Fast Healthcare Interoperability Resources (FHIR)–Based Quality Information Exchange for Clinical Next-Generation Sequencing Genomic Testing: Implementation Study Authors of this article: 2Smart Healthcare Research Institute, Samsung Medical Center, Seoul, Republic of Korea 3Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea 4School of Big Data Science, Data Science Convergence Research Center, Hallym University, Chuncheon, Republic of Korea 5Department of Digital Health, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea *these authors contributed equally Abstract Background: Next-generation sequencing (NGS) technology has been rapidly adopted in clinical practice, with the scope extended to early diagnosis, disease classification, and treatment planning. As the number of requests for NGS genomic testing increases, substantial efforts have been made to deliver the testing results clearly and unambiguously. For the legitimacy of clinical NGS genomic testing, quality information from the process of producing genomic data should be included within the results. However, most reports provide insufficient quality information to confirm the reliability of genomic testing owing to the complexity of the NGS process. Objective: The goal of this study was to develop a Fast Healthcare Interoperability Resources (FHIR)–based web app, NGS Quality Reporting (NGS-QR), to report and manage the quality of the information obtained from clinical NGS genomic tests. Methods: We defined data elements for the exchange of quality information from clinical NGS genomic tests, and profiled a FHIR genomic resource to enable information exchange in a standardized format. We then developed the FHIR-based web app and FHIR server to exchange quality information, along with statistical analysis tools implemented with the R Shiny server. Results: Approximately 1000 experimental data entries collected from the targeted sequencing pipeline CancerSCAN designed by Samsung Medical Center were used to validate implementation of the NGS-QR app using real-world data. The user can share the quality information of NGS genomic testing and verify the quality status of individual samples in the overall distribution. Conclusions: This study successfully demonstrated how quality information of clinical NGS genomic testing can be exchanged in a standardized format. As the demand for NGS genomic testing in clinical settings increases and genomic data accumulate, quality information can be used as reference material to improve the quality of testing. This app could also motivate laboratories to perform diagnostic tests to provide high-quality genomic data. J Med Internet Res 2021;23(4):e26261 Conclusions This study successfully demonstrated how the quality information of clinical NGS genomic testing can be exchanged using a standardized method. As the demand for NGS genomic testing increases and genomic data accumulate, quality information can be used as reference material for improving the quality of testing. This approach can also motivate laboratories to perform diagnostic tests to provide high-quality genomic data. Acknowledgments This work was supported by the Industrial Strategic Technology Development Program (grant number 10078282) funded by the Ministry of Trade, Industry & Energy (MOTIE) and by the Korea Health Technology R&D Project (grant number HI19C1026) through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea. Conflicts of Interest References Kamps R, Brandão RD, Bosch BJVD, Paulussen ADC, Xanthoulea S, Blok MJ, et al. Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification. Int J Mol Sci 2017 Jan 31;18(2):308 [ FREE Full text ] [ CrossRef ] [ Medline ] Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. N Engl J Med 2014 Jun 19;370(25):2418-2425. [ CrossRef ] [ Medline ] Katsanis SH, Katsanis N. Molecular genetic testing and the future of clinical genomics. Nat Rev Genet 2013 Jun;14(6):415-426 [ FREE Full text ] [ CrossRef ] [ Medline ] Tarczy-Hornoch P, Amendola L, Aronson SJ, Garraway L, Gray S, Grundmeier RW, et al. A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record. Genet Med 2013 Oct;15(10):824-832 [ FREE Full text ] [ CrossRef ] [ Medline ] Davis KW, Hamby Erby L, Fiallos K, Martin M, Wassman ER. A comparison of genomic laboratory reports and observations that may enhance their clinical utility for providers and patients. Mol Genet Genomic Med 2019 Jul;7(7):e00551. [ CrossRef ] [ Medline ] Knoppers BM, Zawati MH, Sénécal K. Return of genetic testing results in the era of whole-genome sequencing. Nat Rev Genet 2015 Sep;16(9):553-559. [ CrossRef ] [ Medline ] Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST, Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011 Jul;13(7):680-685. [ CrossRef ] [ Medline ] Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015 May;17(5):405-424 [ FREE Full text ] [ CrossRef ] [ Medline ] Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn 2017 Jan;19(1):4-23 [ FREE Full text ] [ CrossRef ] [ Medline ] Haga SB, Mills R, Pollak KI, Rehder C, Buchanan AH, Lipkus IM, et al. Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding. Genome Med 2014;6(7):58 [ FREE Full text ] [ CrossRef ] [ Medline ] Alterovitz G, Heale B, Jones J, Kreda D, Lin F, Liu L, et al. FHIR Genomics: enabling standardization for precision medicine use cases. NPJ Genom Med 2020;5:13. [ CrossRef ] [ Medline ] ISO/TS 20428:2017 Health informatics — Data elements and their metadata for describing structured clinical genomic sequence information in electronic health records. ISO. URL: https://www.iso.org/standard/67981.html [accessed 2021-04-20] ISO/PRF TS 22693 Genomics informatics — Structured clinical gene fusion report in electronic health records. ISO. URL: https://www.iso.org/standard/73694.html [accessed 2021-04-20] Ryu B, Shin S, Baek R, Kim J, Heo E, Kang I, et al. Clinical genomic sequencing reports in electronic health record systems based on international standards: implementation study. J Med Internet Res 2020 Aug 10;22(8):e15040 [ FREE Full text ] [ CrossRef ] [ Medline ] ISO/TS 22692:2020 Genomics informatics— Quality control metrics for DNA sequencing. ISO. URL: https://www.iso.org/standard/73693.html [accessed 2021-04-20] ISO/DTS 22690 Genomics informatics — Reliability assessment criteria for high-throughput gene-expression data. ISO. URL: https://www.iso.org/standard/73691.html [accessed 2021-04-20] Seong D, Chung J, Lee K, Kim S, Kim B, Song J, et al. Benchmark database for process optimization and quality control of clinical cancer panel sequencing. Biotechnol Bioproc E 2019 Oct 25;24(5):793-798. [ CrossRef ] Patel NM, Jo H, Eberhard DA, Yin X, Hayward MC, Stein MK, et al. Improved tumor purity metrics in next-generation sequencing for clinical practice: the Integrated Interpretation of Neoplastic Cellularity and Sequencing Results (IINCaSe) approach. Appl Immunohistochem Mol Morphol 2019;27(10):764-772 [ FREE Full text ] [ CrossRef ] [ Medline ] Clinical Laboratory Improvement Amendments (CLIA). US Centers for Medicare and Medicaid Services (CMS). URL: https://www.cms.gov/Regulations-and-Guidance/Legislation/CLIA [accessed 2021-04-20] Considerations for Design, Development, and Analytical Validation of Next Generation Sequencing-Based In Vitro Diagnostics Intended to Aim in the Diagnosis of Suspected Germline Diseases. US Food and Drug Administration (FDA). 2018. URL: https://www.fda.gov/media/99208/download [accessed 2021-04-20] Kim J, Park W, Kim NKD, Jang SJ, Chun S, Sung C, Molecular Pathology Study Group of Korean Society of Pathologists. Good Laboratory Standards for clinical next-generation sequencing cancer panel tests. J Pathol Transl Med 2017 May;51(3):191-204. [ CrossRef ] [ Medline ] Lehne M, Sass J, Essenwanger A, Schepers J, Thun S. Why digital medicine depends on interoperability. NPJ Digit Med 2019;2:79. [ CrossRef ] [ Medline ] Mandl KD, Mandel JC, Kohane IS. Driving innovation in health systems through an apps-based information economy. Cell Syst 2015 Jul;1(1):8-13 [ FREE Full text ] [ CrossRef ] [ Medline ] Mandel JC, Kreda DA, Mandl KD, Kohane IS, Ramoni RB. SMART on FHIR: a standards-based, interoperable apps platform for electronic health records. J Am Med Inform Assoc 2016 Sep;23(5):899-908 [ FREE Full text ] [ CrossRef ] [ Medline ] Dolin RH, Boxwala A, Shalaby J. A pharmacogenomics clinical decision support service based on FHIR and CDS hooks. Methods Inf Med 2018 Dec;57(S02):e115-e123 [ FREE Full text ] [ CrossRef ] [ Medline ] Sayeed R, Gottlieb D, Mandl KD. SMART Markers: collecting patient-generated health data as a standardized property of health information technology. NPJ Digit Med 2020;3:9. [ CrossRef ] [ Medline ] Alterovitz G, Warner J, Zhang P, Chen Y, Ullman-Cullere M, Kreda D, et al. SMART on FHIR Genomics: facilitating standardized clinico-genomic apps. J Am Med Inform Assoc 2015 Nov;22(6):1173-1178. [ CrossRef ] [ Medline ] Warner JL, Rioth MJ, Mandl KD, Mandel JC, Kreda DA, Kohane IS, et al. SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care. J Am Med Inform Assoc 2016 Jul;23(4):701-710 [ FREE Full text ] [ CrossRef ] [ Medline ] Warner JL, Prasad I, Bennett M, Arniella M, Beeghly-Fadiel A, Mandl KD, et al. SMART Cancer Navigator: A framework for implementing ASCO Workshop recommendations to enable precision cancer medicine. JCO Precis Oncol 2018;2018:PO.17.00292 [ FREE Full text ] [ CrossRef ] [ Medline ] Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Working Group of the American College of Medical GeneticsGenomics Laboratory Quality Assurance Commitee. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 2013 Sep;15(9):733-747 [ FREE Full text ] [ CrossRef ] [ Medline ] Aziz N, Zhao Q, Bry L, Driscoll DK, Funke B, Gibson JS, et al. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med 2015 Apr;139(4):481-493 [ FREE Full text ] [ CrossRef ] [ Medline ] FHIR Resource MolecularSequence. HL7.org. URL: https://www.hl7.org/fhir/molecularsequence.html [accessed 2021-04-20] Quality control metrics for DNA sequencing. SIMPLIFIER.NET. URL: https://simplifier.net/qualtiycontorlmetricsfordnasequencing [accessed 2021-04-20] Deployment of NGS-QR app. Heroku.com. URL: https://ngs-qr.herokuapp.com [accessed 2021-04-20] NGS Quality Reporting (NGS-QR) App. SMART App Gallery. URL: https://apps.smarthealthit.org/app/ngs-quality-reporting-ngs-qr-app [accessed 2021-04-20] NGS Quality Reporting App. GitHub.com. URL: https://github.com/dhseong/ngs-qr-app-client [accessed 2021-04-20] Deployment of Shiny app for statistical analysis in NGS-QR app. Shinyapp.io. URL: https://dhseong.shinyapps.io/NGS-QR-App [accessed 2021-04-20] R code for statistical analysis in NGS-QR app. GitHub.com. URL: https://github.com/dhseong/Statistics-for-NGS-QR-app [accessed 2021-04-20] FHIR Security. HL7.org. URL: https://www.hl7.org/fhir/security.html [accessed 2021-04-20] Transport Layer Security (TLS) Protocol. URL: https://tools.ietf.org/html/rfc5246 [accessed 2021-04-20] OAuth 2.0 Authorization Framework. URL: https://tools.ietf.org/html/rfc6749 [accessed 2021-04-20] Kim ST, Kim K, Kim NKD, Park JO, Ahn S, Yun J, et al. Clinical application of targeted deep sequencing in solid-cancer patients and utility for biomarker-selected clinical trials. Oncologist 2017 Oct;22(10):1169-1177. [ CrossRef ] [ Medline ] Shin H, Choi Y, Yun JW, Kim NKD, Kim S, Jeon HJ, et al. Prevalence and detection of low-allele-fraction variants in clinical cancer samples. Nat Commun 2017 Nov 09;8(1):1377. [ CrossRef ] [ Medline ] ‎

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing FAST Healthcare

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned FAST Healthcare in 1 CB Insights research brief, most recently on Mar 23, 2021.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.